Promedius Secures 21.5 Billion Won Investment... Naver and Daewoong Pharmaceutical Also Impressed
Summary
Promedius raised 21.5 billion won in a Series B round, pushing its cumulative funding above 35 billion won. The company develops AI healthcare software that screens osteoporosis risk in three seconds using chest X-rays. New investors included both financial backers and strategic partners such as Naver and Daewoong Pharmaceutical. Promedius plans to pursue technical evaluation for a tech IPO next year while also seeking FDA and CE MDR approvals for its Osteo Signal product.
Funding
Amount
$15.9M
Total raised
Date
June 5, 2026
Announcement date
Investors
SL Investment, Asan Medical Center
Lead investors
Company
promedius.com
Funded company
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected